<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20191208045659N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-12-28</date_registration>
      <primary_sponsor>Semnan University of Medical Sciences</primary_sponsor>
      <public_title>effect of Lavender essential oil and Alprazolam on anesthesia and hemodynamic parameters during general anesthesia process</public_title>
      <acronym></acronym>
      <scientific_title>Compare the effectiveness of Lavender essential oil and Alprazolam on anesthesia and hemodynamic parameters during general anesthesia process</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-01-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/44139</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: The current study aims to help expand the use of non-pharmacological methods in the anesthesia and surgery process, Randomization description: Using random number tables (random blocks A, B, C), patients are placed in one of intervention groups 1 (alprazolam), intervention group 2 (lavender scent) and group 3 (control group), Blinding description: Premeditation  therapy with alprazolam for group 1 and aromatherapy for group 2,  will be  performed by the researcher in the morning of surgery day. The person who evaluating the depth of anesthesia and the statistical analyst does not know the type of pre-medication received by the patient or whether he is in the intervention or control group.</study_design>
      <phase>3</phase>
      <hc_freetext>Condition 1: Fractures of various organs that are surgically repaired under anesthesia. Condition 2: Femoral neck fracture. Condition 3: Fracture of the bones of the right hand. Condition 4: Fracture of the bones of the left hand. Condition 5: Abdominal and gastrointestinal surgeries.</hc_freetext>
      <i_freetext>Intervention 1: 2-3 hours before surgery premed will be administrated.  For group 1, the dose of oral alprazolam is 0.5 mg. Intervention 2: Intervention group: 3 drops of lavender that is poured on a clean cloth or gauze and inhaled for 15-20 minutes. Intervention 3: Control group: As a control group, they receive only routine medications.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Baseline data of participants' such as age, sex, and kind of disease, intervention, and outcomes could be available to others through the publication of articles

When:
It is available to everyone indefinitely by publishing the article

To whom:
research center of Semnan University of Medical Sciences and researchers in the field of anesthesiology and intensive care could access the anonymous documentation by providing appropriate reasons.

Conditions:
The main finding data will be available to the public through articles. More detailed data will be made available to researchers and specialists through correspondence with the research team

Where to obtain:
By contact with the Correspond author in the published articles

How to obtain:
Introduce himself and mentioning personal, professional and organizational characteristics as well as the reasons for accessing to more detailed information and how to use this information.

Comments:
It seems that through the publication of the articles, the main research findings can be  available to practitioners and researchers in anesthesiology and intensive care fields.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sefollah Alaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Damghan Road, Semnan University of Medical Sciences</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3514993437</zip>
        <telephone>+98 23 3365 4190</telephone>
        <email>alaei@semums.ac.ir</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Abolfazl Abdullah Pour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Amin</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3519735763</zip>
        <telephone>009831420</telephone>
        <email>ّFelordce@yahoo.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Class I and  II Anesthesia,
Age group 15-60 years
Not have serious illnesses and problems affecting body function and thermodynamics such as diabetes and cardiovascular disease</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of mental illness or brain injury,
current use of sedatives, opiates, psychotropics drugs, patients who do not cooperate,
history of allergies or olfactory problems,
pre- and inoperative body temperature rise,
use of medications effective on sleep  (such as phenobarbital)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>S72.04</hc_code>
      <hc_code>S72.043</hc_code>
      <hc_code>S62.91XA</hc_code>
      <hc_code>S62.92XA</hc_code>
      <hc_code>S39.91XA</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Fracture of base of neck of femur</hc_keyword>
      <hc_keyword>Displaced fracture of base of neck of unspecified femur</hc_keyword>
      <hc_keyword>Unspecified fracture of right wrist and hand</hc_keyword>
      <hc_keyword>Unspecified fracture of right wrist and hand</hc_keyword>
      <hc_keyword>Abdominal surgeries</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>2-3 hours before surgery premed will be administrated.  For group 1, the dose of oral alprazolam is 0.5 mg.</i_keyword>
      <i_keyword>Intervention group: 3 drops of lavender that is poured on a clean cloth or gauze and inhaled for 15-20 minutes.</i_keyword>
      <i_keyword>Control group: As a control group, they receive only routine medications</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The depth of anesthesia is evaluated peroperation and immediately after surgery. Timepoint: Depth of anesthesia during surgery for 3 times will be assessed. The assessment time is in starting of surgery, mid-surgery and finishing the last part of surgery and also after surgery, 5 minutes after being placed on the recovery bed . Method of measurement: Depth of anesthesia is measured by the Bispectral index (BIS) device. The patient's blood pressure is also measured using a digital blood pressure monitor.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Vital sign include the patient's breathing, pulse rate and blood pressure measured by the assessor as well as with the help of a digital Sphygmomanometer. Timepoint: Vital signs will be measured before prescription medication, 5 minutes after surgery, before anesthesia, at the time of surgery, mid-surgery, and after the last part of the surgical intervention. . It will be also measured 5 minutes after surgery on the recovery bed. Method of measurement: By the assessor as well as with the help of a digital Sphygmomanometer.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Semnan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-11-18</approval_date>
        <contact_name>Semnan University of Medical Sciences Ethics Committee</contact_name>
        <contact_address>Damghan Road, Semnan University of Medical Sciences Semnan Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
